Hence, we decided to group herein all the patients under the term “MMCS KIT 816−/+” because of the overlap with systemic mastocytosis and its complications (severe anaphylaxis, osteoporosis)–even though the disease could be considered to be less advanced. Here, KIT is linked to systemic mastocytosis.